A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance

A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance

Dettagli Bibliografici
Autori principali:	Carballo, S, Blair, E, Watkins, H
Natura:	Conference item
Pubblicazione:	2004

Documenti analoghi

Autosomal dominant familial dilated cardiomyopathy caused by a novel mutation in phospholamban
di: Carballo, S, et al.
Pubblicazione: (2004)

Autosomal dominant HCM and DCM phenotype caused by a novel mutation in phospholamban
di: Carballo, S, et al.
Pubblicazione: (2004)

Identification and functional analysis of cardiac troponin I as a novel disease gene in autosomal dominant familial dilated cardiomyopathy
di: Carballo, S, et al.
Pubblicazione: (2006)

Early onset malignant hypertrophic cardiomyopathy caused by mutations in MYBPC3
di: Carballo, S, et al.
Pubblicazione: (2003)

Novel mutations in cardiac MYBPC3 causing early onset malignant hypertrophic cardiomyopathy
di: Carballo, S, et al.
Pubblicazione: (2005)

A rare cause of mixed hypertrophic and dilated phenotype cardiomyopathy – the MELAS syndrome
di: Casian Mihnea, et al.
Pubblicazione: (2023-09-01)

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
di: Carballo, S, et al.
Pubblicazione: (2005)

Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy.
di: Carballo, S, et al.
Pubblicazione: (2009)

Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathies
di: Paradossi Umberto, et al.
Pubblicazione: (2008-12-01)

Novel mutations in cardiac MYBPC3 and early onset malignant hypertrophic cardiomyopathy
di: Carballo, S, et al.
Pubblicazione: (2005)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
di: Robinson, P, et al.
Pubblicazione: (2002)

Structures of PKA–phospholamban complexes reveal a mechanism of familial dilated cardiomyopathy
di: Juan Qin, et al.
Pubblicazione: (2022-03-01)

Autosomal recessive transmission of MYBPC3 mutation results in malignant phenotype of hypertrophic cardiomyopathy.
di: Yilu Wang, et al.
Pubblicazione: (2013-01-01)

Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
di: Blair, E, et al.
Pubblicazione: (2001)

Double mutations in CIS can confound genotype-phenotype correlations in hypertrophic cardiomyopathy
di: Blair, E, et al.
Pubblicazione: (2000)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
di: Watkins, H
Pubblicazione: (2003)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
di: Blair, E, et al.
Pubblicazione: (2003)

A novel heterozygous missense MYH7 mutation potentially causes an autosomal dominant form of myosin storage myopathy with dilated cardiomyopathy
di: Niloofar Naderi, et al.
Pubblicazione: (2023-10-01)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
di: Suttie, J, et al.
Pubblicazione: (2011)

Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy
di: Rayner, JJ, et al.
Pubblicazione: (2020)

Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the <it>MYBPC3 </it>gene
di: Lehrke Stephanie, et al.
Pubblicazione: (2008-10-01)

Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
di: Hamza El Hadi, et al.
Pubblicazione: (2023-02-01)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
di: Seitaro Nomura, et al.
Pubblicazione: (2023-03-01)

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
di: Enrica Chiti, et al.
Pubblicazione: (2021-09-01)

Hearing Profile in Patients with Dilated and Hypertrophic Cardiomyopathies
di: Gehan Abd El-Rahman El-Zarea, et al.
Pubblicazione: (2016-02-01)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
di: Hudsmith, L, et al.
Pubblicazione: (2006)

Dilated cardiomyopathy and the desmin gene.
di: Mayosi, B, et al.
Pubblicazione: (2000)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
di: Abdulrazzak, H, et al.
Pubblicazione: (2001)

Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
di: Robinson, P, et al.
Pubblicazione: (2007)

Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
di: Shiv Kumar Viswanathan, et al.
Pubblicazione: (2017-01-01)

Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy
di: Niels Grote Beverborg, et al.
Pubblicazione: (2021-08-01)

Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations
di: Lina Basel-Vanagaite, et al.
Pubblicazione: (2008-06-01)

Intrafamilial phenotypic variability of DNAJB6 mutation associated autosomal dominantly inherited myopathy: a family report and literature review
di: LI Fan, et al.
Pubblicazione: (2021-03-01)

Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
di: Megan J. Puckelwartz, et al.
Pubblicazione: (2021-04-01)

Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
di: Jiri Bonaventura, et al.
Pubblicazione: (2023-06-01)

Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
di: Lakdawala, N, et al.
Pubblicazione: (2010)

Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes
di: Lorenzo Alamo, et al.
Pubblicazione: (2017-06-01)

Phospholamban overexpression in mice causes a centronuclear myopathy-like phenotype
di: Val A. Fajardo, et al.
Pubblicazione: (2015-08-01)

Digenic Inheritance of LAMA4 and MYH7 Mutations in Patient with Infantile Dilated Cardiomyopathy
di: Atiyeh M Abdallah, et al.
Pubblicazione: (2019-01-01)

A Case Study Identified a New Mutation in the TTN Gene for Inherited Hypertrophic Cardiomyopathy
di: Dong J, et al.
Pubblicazione: (2025-01-01)